🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since MarchSee the stock

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Published 22/12/2023, 18:28
© Reuters.  Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

AAR reported quarterly sales of $545.4 million, up 16% Y/Y, missing the consensus of $557.2 million. Adjusted EPS from continuing operations rose 17% Y/Y to 81 cents, beating the consensus of 80 cents.

AAR recently disclosed the buyout of the Product Support business of Triumph Group Inc (NYSE: TGI) for $725 million.

AAR shares fell 7% to $65.82 on Friday.

Here are some other stocks moving in today's mid-day session.


  • NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 263% to $3.29.
  • Jin Medical International Ltd. (NASDAQ: ZJYL) gained 71% to $120.50.
  • Daseke, Inc. (NASDAQ: DSKE) gained 64.8% to $8.10 after the company announced it will be acquired by TFI International.
  • Royalty Management Holding Corporation (NASDAQ: RMCO) jumped 59% to $3.18. Royalty Management Holding announced that Ferrox Holdings confirmed the commencement of production of titanium ferrite from its Tivani operating site.
  • Karuna Therapeutics, Inc. (NASDAQ: KRTX) shares gained 46.9% to $316.20. Bristol Myers Squibb & Co (NYSE: BMY) agreed to acquire Karuna Therapeutics for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired.
  • Polished.com Inc. (NYSE: POL) rose 46% to $5.91.
  • Esports Entertainment Group, Inc. (NASDAQ: GMBL) jumped 40.8% to $5.92.
  • Argo Blockchain plc (NASDAQ: ARBK) gained 35% to $3.4801.
  • PureTech Health plc (NASDAQ: PRTC) climbed 33.8% to $24.95 after the company announced that its Founded Entity, Karuna Therapeutics, entered into a definitive merger agreement to be acquired by Bristol Myers Squibb.
  • Snow Lake Resources Ltd. (NASDAQ: LITM) rose 29.6% to $1.1389.
  • Asset Entities Inc. (NASDAQ: ASST) rose 25.9% to $0.8310 after jumping 45% on Thursday. Asset Entities, last month, announced a stock repurchase program.
  • Rocket Lab USA, Inc. (NASDAQ: RKLB) shares gained 25% to $5.54 after the company announced a new $515 million contract with a U.S. government customer.
  • Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 23.6% to $2.8150. Enlivex Therapeutics recently announced that it completed enrollment of all 120 patients in its Phase II trial of Allocetra in patients with sepsis.
  • Atara Biotherapeutics, Inc. (NASDAQ: ATRA) shares rose 22.4% to $0.5466 after the company announced the closing of the expanded global partnership with Pierre Fabre Laboratories for tabelecleucel.
  • Neumora Therapeutics, Inc. (NASDAQ: NMRA) surged 20.2% to $16.81.
  • Canaan Inc. (NASDAQ: CAN) gained 20% to $3.10.
  • Wheels Up Experience Inc. (NYSE: UP) rose 19.3% to $3.2801.
  • Bitdeer Technologies Group (NASDAQ: BTDR) gained 16.6% to $9.85.
  • MoneyLion Inc. (NYSE: ML) surged 14.6% to $64.42.
  • Tourmaline Bio, Inc. (NASDAQ: TRML) rose 14.3% to $23.01.
  • ALX Oncology Holdings Inc. (NASDAQ: ALXO) jumped 13.6% to $14.81.
  • Allogene Therapeutics, Inc. (NASDAQ: ALLO) gained 13.5% to $3.1333.
  • Mineralys Therapeutics, Inc. (NASDAQ: MLYS) rose 13% to $8.44. Mineralys said first subject dosed in Launch-HTN, the second pivotal trial of lorundrostat for treatment of hypertension.
  • ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) surged 11.5% to $11.71.
  • Jin Medical International Ltd. (NASDAQ: ZJYL) gained 11.5% to $78.62.
  • ImmunityBio, Inc. (NASDAQ: IBRX) shares rose 11.2% to $4.5350 after declining 10% on Thursday.
  • Apogee Therapeutics, Inc. (NASDAQ: APGE) jumped 10.3% to $28.17.
  • ANSYS, Inc. (NASDAQ: ANSS) gained 10.2% to $334.05.
  • Fulcrum Therapeutics, Inc. (NASDAQ: FULC) rose 10.2% to $6.36.
  • Prime Medicine, Inc. (NASDAQ: PRME) gained 9% to $9.55.
  • Compass, Inc. (NYSE: COMP) gained 8.7% to $3.50.
  • Altair Engineering Inc. (NASDAQ: ALTR) surged 8.3% to $80.95 after JP Morgan initiated coverage on the stock with an Overweight rating and $86 price target.
  • AlloVir, Inc. (NASDAQ: ALVR) shares dipped 66.1% to $0.7904 after the company provided an update on its three Phase 3 clinical trials with posoleucel, an investigational off-the-shelf multi-virus-specific T cell therapy, which targets six viral pathogens in immunocompromised individuals: adenovirus (AdV), BK virus (BKV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus-6 (HHV-6) and JC virus (JCV).
  • Jayud Global Logistics Limited (NASDAQ: JYD) fell 46% to $1.49.
  • Netcapital Inc. (NASDAQ: NCPL) shares fell 36% to $0.2114 after the company announced pricing of a $4 million public offering.
  • Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares fell 34.2% to $0.2050 after announcing a $2 million registered direct offering of common stock.
  • Banyan Acquisition Corporation (NYSE: BYN) fell 28.5% to $7.79.
  • ParaZero Technologies Ltd. (NASDAQ: PRZO) dipped 27% to $1.1700.
  • Linkage Global Inc (NASDAQ: LGCB) fell 24.4% to $1.77. Linkage Global recently priced $6 million initial public offering of 1.5 million ordinary shares at $4 per share.
  • Cemtrex, Inc. (NASDAQ: CETX) fell 20.3% to $5.18 following quarterly results.
  • ATIF Holdings Limited (NASDAQ: ATIF) dipped 20% to $0.8390.
  • Lottery.com Inc. (NASDAQ: LTRY) fell 18% to $3.01.The company’s shares jumped 196% on Thursday after the company announced an $18 million investment commitment from Prosperity Investment Management.
  • 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares fell 17.3% to $0.9103 after declining around 6% on Thursday.
  • Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) fell 17.1% to $2.9850 after the company announced a registered direct and private placement offering priced at-the-market under Nasdaq rules.
  • Brooge Energy Limited (NASDAQ: BROG) fell 16.4% to $3.3590.
  • Mullen Automotive, Inc. (NASDAQ: MULN) shares fell 15.9% to $11.98. Mullen Automotive shares jumped 78% on Thursday amid increased volatility following the company's 1-for-100 reverse split, and after the company announced 38 additional Class 3 vehicles have been delivered to Randy Marion Automotive Group with the company invoicing RMA for $2.5 million.
  • NetEase, Inc. (NASDAQ: NTES) fell 14.9% to $88.81 after China unveiled draft rules aimed at curbing spending on online gaming.
  • Nanobiotix S.A. (NASDAQ: NBTX) shares declined 13.8% to $6.62 after jumping more than 15% on Thursday.
  • NIKE, Inc. (NYSE: NKE) shares fell 10.8% to $109.31. NIKE posted better-than-expected earnings for its second quarter, but sales missed expectations. The company also stated that it is assessing opportunities to deliver up to $2 billion in cumulative cost savings during the next three years.
  • HUYA Inc. (NYSE: HUYA) shares declined 9.8% to $3.2750. HUYA entered into definitive agreement to acquire a global mobile application service provider.
  • Foot Locker, Inc. (NYSE: FL) declined 5.5% to $30.54. Shares of footwear and athletic apparel stocks traded lower in sympathy with Nike, which fell after reporting mixed second-quarter results, lowering its outlook and announcing cost savings plans.

Now Read This: Ethereum Hits $2,300 Following PCE Data; Optimism Emerges As Top Gainer

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.